OCT 17, 2017 8:00 AM PDT

WEBINAR: Transcriptomics to decipher the pathobiology of drug resistance and enable targeted therapeutics

Speaker
  • Assistant Research Professor, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine
    Biography
      Dr. Yesim Gökmen-Polar is an Assistant Research Professor in the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine. Her research interests are centered on the identification of novel therapeutic targets in breast and thymic cancers resistant to standard of care therapy. She has approximately 50 publications mainly in the field of cancer biology. Her specific expertise is in development of novel therapeutic targets (i.e. targeting EphA2 receptor tyrosine kinase, protein kinase C beta, anti-tubulins and TORC1/2) in colon, breast cancer and thymic malignancies. Her lab developed and characterized a novel human thymoma model, designated as IU-TAB-1, which was derived from a patient with the stage II thymoma (WHO type A/B). Dr. Gökmen-Polar's current research uses next generation sequencing (NGS), next generation microarrays such as Clariom D Human Transcriptome Analysis, and preclinical models to understand the transcriptional regulation/mechanisms of resistance and develop novel targeted therapies. The ultimate goal of her research is to prevent development of recurrences and improve the quality of life for patients.

    Abstract

    DATE: October 17, 2017
    TIME: 08:00am PDT, 11:00am EDT

    Researching and understanding the mechanisms of drug resistance are essential to determine therapies that are more effective on an individual basis. Computational biology tools combined with transcriptome analysis allow the characterization of differential gene expression signatures in response to treatment in resistant vs non-resistant human-derived cancer cells. Many biomarkers including non-coding RNAs and alternatively spliced variants have been associated with tumor pathogenesis or drug resistance. These biomarkers represent candidates to help elucidate the biology of diseases, to identify the mechanisms for drug resistance, and to design better targeted therapies for precision medicine.

     

    In this webinar, the speaker will:

    • Explain the importance of non-coding RNAs and alternative splicing in cancer biology
    • Describe transcriptomics workflows to identify biomarkers and drug resistance mechanisms
    • Share applications in breast and thymic cancer research

     

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    OCT 17, 2017 8:00 AM PDT

    WEBINAR: Transcriptomics to decipher the pathobiology of drug resistance and enable targeted therapeutics


    Specialty

    Cancer Research

    Molecular Biology

    Molecular Diagnostics

    Biomarkers

    Cell Biology

    Biotechnology

    Genomics

    Genetics

    Cancer Diagnostics

    Immunology

    Gene Expression

    Dna

    Dna Sequencing

    Cancer Therapeutics

    Bioinformatics

    Geography

    North America57%

    Europe23%

    Asia9%

    South America5%

    Africa2%

    Oceania1%

    Registration Source

    Website Visitors100%

    Job Title

    Student20%

    Research Scientist18%

    Executive10%

    Scientist10%

    Educator/Faculty9%

    Post Doc8%

    Facility/Department Manager7%

    Medical Laboratory Technician6%

    Lab Management4%

    Medical Doctor/Specialist4%

    Clinical Laboratory Scientist4%

    Marketing/Sales2%

    Organization

    Academic Institution13%

    Biotech Company7%

    Clinical Laboratory7%

    Research Institute6%

    Hospital4%

    Life Science Company2%

    Medical Center2%

    Consultant2%

    Medical School2%

    Government2%

    Pharmaceutical Company2%

    Non-Profit Organization1%

    Ambulatory Care1%

    Medical Device Company1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more